Acceptance rate, hesitancy and comorbidities in pregnant women
A COVID-19 vaccination status
Keywords:
Comorbidities, Hesitancy and Acceptance rate of COVID-19, Brand Preference, E-dataAbstract
We analyzed the electronic data (e-data) of n=5231 vaccinated candidates including n=3671 males and n=1560 females. We studied the COVID-19 vaccine brands such as Sino pharm, CanSino, SinoVac, Moderna and Pfizer. We noted adverse effects in post-vaccinated candidates were Instability in blood pressure 29.5%, Swelling 3.5%, Redness 14.2%, Itching 7.13%, and Rashes 2.4%. Comorbidities in the vaccinated candidates such as Hypertension 33%, Diabetes mellitus 17%, Kidney disease 42%, and Chronic respiratory disease 9%. COVID-19 vaccine hesitancy 1153, 22% and Non-Hesitant 4078, 77%. We analyzed the e-data of COVID-19 vaccinated candidates, the acknowledgement of COVID-19 immunization in pregnant women. Worrying about vaccine safety was the significant justification for hesitancy. Recognizing mentalities among study groups will be valuable for coming up with vaccine strategies that increment the ongoing pandemic.
Downloads
References
Center LPJN. Evaluation of Blood parameters, COVID-19 Vaccine Adverse effects, Hesitancy, and Acceptance rate in Pregnant Women: A Cross-sectional study. 2023;21(3):78-87.
Fauci AS, Lane HC, Redfield RRJNEJoM. COVID-19—navigating the uncharted. Mass Medical Soc; 2020. p. 1268-9.
Scalinci SZ, Battagliola ETJI. Conjunctivitis can be the only presenting sign and symptom of COVID-19. 2020;20:e00774.
y Galán JTGJN. Stroke as a complication and prognostic factor of COVID-19. 2020;35(5):318-22.
Le TT, Andreadakis Z, Kumar A, Román RG, Tollefsen S, Saville M, et al. The COVID-19 vaccine development landscape. 2020;19(5):305-6.
Ibrahim NKJJoi, health p. Epidemiologic surveillance for controlling COVID-19 pandemic: types, challenges and implications. 2020;13(11):1630-8.
French M, Monahan TJS, Society. Dis-ease surveillance: How might surveillance studies address COVID-19? 2020;18(1):1-11.
Organization WH. Global surveillance for COVID-19 caused by human infection with COVID-19 virus: interim guidance, 20 March 2020. World Health Organization; 2020.
Syed Anwar Aly SA, Abdul Rahman R, Sharip S, Shah SA, Abdullah Mahdy Z, Kalok AJIjoer, et al. Pregnancy and COVID-19 pandemic perception in Malaysia: A cross-sectional study. 2021;18(11):5762.
Yang Z, Wang M, Zhu Z, Liu YJTjom-f, medicine n. Coronavirus disease 2019 (COVID-19) and pregnancy: a systematic review. 2022;35(8):1619-22.
Wang C-L, Wu C-H, Wang C-Y, Wang C-H, Long C-YJIjoms. Impact of COVID-19 on Pregnancy. 2021;18(3):763.
Schmid MB, Fontijn J, Ochsenbein-Kölble N, Berger C, Bassler DJTLID. COVID-19 in pregnant women. 2020;20(6):653.
Liu H, Wang L-L, Zhao S-J, Kwak-Kim J, Mor G, Liao A-HJJori. Why are pregnant women susceptible to COVID-19? An immunological viewpoint. 2020;139:103122.
London V, McLaren Jr R, Atallah F, Cepeda C, McCalla S, Fisher N, et al. The relationship between status at presentation and outcomes among pregnant women with COVID-19. 2020;37(10):991-4.
Rasmussen SA, Jamieson DJJO, gynecology. Coronavirus disease 2019 (COVID-19) and pregnancy: responding to a rapidly evolving situation. 2020.
Published
How to Cite
Issue
Section
Copyright (c) 2023 International journal of health sciences
![Creative Commons License](http://i.creativecommons.org/l/by-nc-nd/4.0/88x31.png)
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Articles published in the International Journal of Health Sciences (IJHS) are available under Creative Commons Attribution Non-Commercial No Derivatives Licence (CC BY-NC-ND 4.0). Authors retain copyright in their work and grant IJHS right of first publication under CC BY-NC-ND 4.0. Users have the right to read, download, copy, distribute, print, search, or link to the full texts of articles in this journal, and to use them for any other lawful purpose.
Articles published in IJHS can be copied, communicated and shared in their published form for non-commercial purposes provided full attribution is given to the author and the journal. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
This copyright notice applies to articles published in IJHS volumes 4 onwards. Please read about the copyright notices for previous volumes under Journal History.